Hematologic Oncology Update

Auteur(s): Research To Practice
  • Résumé

  • Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
    Copyright 2025 Research To Practice. All Rights Reserved
    Voir plus Voir moins
Épisodes
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
    Feb 25 2025

    Prof Martin Hutchings from Copenhagen University Hospital in Denmark, Dr Manali Kamdar from the University of Colorado Cancer Center, Dr Matthew Lunning from the University of Nebraska Medical Center and Prof Gilles Salles from Memorial Sloan Kettering Cancer Center in New York summarize currently available data guiding treatment decision-making for patients with relapsed/refractory diffuse large B-cell lymphoma and present cases from their practices.

    CME information and select publications here.

    Voir plus Voir moins
    2 h et 33 min
  • Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
    Feb 19 2025

    Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.

    CME information and select publications here.

    Voir plus Voir moins
    47 min
  • Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
    Feb 11 2025

    Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York discusses available data guiding treatment decision-making for patients with newly diagnosed multiple myeloma.

    CME information and select publications here.

    Voir plus Voir moins
    47 min

Ce que les auditeurs disent de Hematologic Oncology Update

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.